Dimerization of the type 4 cAMP-specific phosphodiesterases is mediated by the upstream conserved regions (UCRs)

被引:78
作者
Richter, W [1 ]
Conti, M [1 ]
机构
[1] Stanford Univ, Sch Med, Dept Gynecol & Obstet, Div Reprod Biol, Stanford, CA 94305 USA
关键词
D O I
10.1074/jbc.M203585200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The cAMP-specific PDE4 family consists of four genes, each expressed as several splice variants. These variants are termed long and short forms depending on the presence or absence of two unique N-terminal domains called upstream conserved regions 1 and 2 (UCR1 and 2). UCR1 and UCR2 have been shown to form a module necessary for the activation of PDE4 upon phosphorylation by the cAMP-dependent kinase (PKA). Here we have uncovered PDE4 oligomerization as a novel function for the UCR1/UCR2 module. Using several different approaches including gel filtration, sucrose density gradient centrifugation, pull-down of differentially tagged PDE constructs, and yeast two-hybrid assay, we show that the long PDE4 splice variant PDE4D3 behaves as a dimer, whereas the short splice variant PDE4D2 is a monomer. Internal deletions of either the C-terminal portion of UCR1 or the N-terminal portion of UCR2 abolishes dimerization of PDE4D3 indicating that both domains are involved in this intermolecular interaction. The dimerization, however, is structurally distinguishable from a previously described intramolecular interaction involving the same domains. PKA phosphorylation and site-directed mutagenesis shown to ablate the latter do not interfere with dimerization. Therefore, dimerization of the long PDE4 forms may be an additional function of the UCR domains that further explains differences in the regulatory properties between the long and short PDE4 splice variants.
引用
收藏
页码:40212 / 40221
页数:10
相关论文
共 44 条
[11]   Ligand-induced conformational changes in cyclic nucleotide phosphodiesterases and cyclic nucleotide-dependent protein kinases [J].
Francis, SH ;
Chu, DM ;
Thomas, MK ;
Beasley, A ;
Grimes, K ;
Busch, JL ;
Turko, IV ;
Haik, TL ;
Corbin, JD .
METHODS, 1998, 14 (01) :81-92
[12]   The cAMP-specific phosphodiesterase PDE4D3 is regulated by phosphatidic acid binding -: Consequences for cAMP signaling pathway and characterization of a phosphatidic acid binding site [J].
Grange, M ;
Sette, C ;
Cuomo, M ;
Conti, M ;
Lagarde, M ;
Prigent, AF ;
Némoz, G .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (43) :33379-33387
[13]   The MAP kinase ERK2 inhibits the cyclic AMP-specific phosphodiesterase HSPDE4D3 by phosphorylating it at Ser579 [J].
Hoffmann, R ;
Baillie, GS ;
MacKenzie, SJ ;
Yarwood, SJ ;
Houslay, MD .
EMBO JOURNAL, 1999, 18 (04) :893-903
[14]  
Houslay MD, 1998, ADV PHARMACOL, V44, P225, DOI 10.1016/S1054-3589(08)60128-3
[15]   PDE4 cAMP-specific phosphodiesterases [J].
Houslay, MD .
PROGRESS IN NUCLEIC ACID RESEARCH AND MOLECULAR BIOLOGY, VOL 69, 2001, 69 :249-315
[16]   CAMP compartmentation is responsible for a local activation of cardiac Ca2+ channels by beta-adrenergic agonists [J].
Jurevicius, J ;
Fischmeister, R .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (01) :295-299
[17]   Functions of the N-terminal region of cyclic nucleotide phosphodiesterase 3 (PDE 3) isoforms [J].
Kenan, Y ;
Murata, T ;
Shakur, Y ;
Degerman, E ;
Manganiello, VC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (16) :12331-12338
[18]   Recombinant expression of a type IV, cAMP-specific phosphodiesterase: Characterization and structure-function studies of deletion mutants [J].
Kovala, T ;
Sanwal, BD ;
Ball, EH .
BIOCHEMISTRY, 1997, 36 (10) :2968-2976
[19]   CLEAVAGE OF STRUCTURAL PROTEINS DURING ASSEMBLY OF HEAD OF BACTERIOPHAGE-T4 [J].
LAEMMLI, UK .
NATURE, 1970, 227 (5259) :680-+
[20]   Purification and characterization, of the human PDE4A catalytic domain (PDE4A330-723) expressed in Sf9 cells [J].
Lario, PL ;
Bobechko, B ;
Bateman, K ;
Kelly, J ;
Vrielink, A ;
Huang, Z .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2001, 394 (01) :54-60